The Analyst Verdict: Cardlytics In The Eyes Of 5 Experts
The Analyst Verdict: Cardlytics In The Eyes Of 5 Experts
分析师的判决：5位专家眼中的Cardlytics
5 analysts have expressed a variety of opinions on Cardlytics (NASDAQ:CDLX) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在过去的一个季度中，有5位分析师对Cardlytics（纳斯达克股票代码：CDLX）表达了不同的观点，从看涨到看跌，提出了各种各样的观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $16.0, a high estimate of $18.00, and a low estimate of $12.00. Surpassing the previous average price target of $12.50, the current average has increased by 28.0%.
分析师12个月目标股价的见解已经公布，平均目标股价为16.0美元，最高估计为18.00美元，低估值为12.00美元。超过了之前的平均目标股价12.50美元，目前的平均价格上涨了28.0％。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析师评级：详细明细
The analysis of recent analyst actions sheds light on the perception of...
对分析师近期行为的分析揭...
登录免费看全文
登录/注册